We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+37.32%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$501M
AUM Growth
+$40.8M
Cap. Flow
-$54.9M
Cap. Flow %
-10.95%
Top 10 Hldgs %
8.76%
Holding
430
New
121
Increased
23
Reduced
166
Closed
120

Sector Composition

Rank Sector Weight
1 Healthcare 21.56%
2 Technology 18.97%
3 Industrials 10.84%
4 Consumer Discretionary 10.81%
5 Financials 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERS icon
26
Cerus
CERS
$575M
$2.94M 0.59%
438,446
-10,755
-2% -$58.4K
STGW icon
27
Stagwell
STGW
$2B
$2.88M 0.57%
154,257
-20,084
-12% -$313K
MEI icon
28
Methode Electronics
MEI
$458M
$2.83M 0.57%
101,263
-57,367
-36% -$1.21M
CLDX icon
29
Celldex Therapeutics
CLDX
$2.94B
$2.82M 0.56%
5,299
-9,442
-64% -$3.24M
DXLG icon
30
Destination XL Group
DXLG
$32.9M
$2.81M 0.56%
433,498
+147,225
+51% +$945K
TPLM
31
DELISTED
Triangle Petroleum Corporation
TPLM
$2.78M 0.55%
282,697
+138,104
+96% +$1.05M
AFOP
32
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
$2.77M 0.55%
135,291
-2,943
-2% -$50.9K
RMTI icon
33
Rockwell Medical
RMTI
$27.2M
$2.76M 0.55%
+2,199
New +$1.49M
KYTH
34
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$2.75M 0.55%
+60,219
New +$1.8M
MOVE
35
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
$2.64M 0.53%
155,854
-21,413
-12% -$309K
RPTP
36
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$2.63M 0.52%
175,761
-48,216
-22% -$578K
INSY
37
DELISTED
Insys Therapeutics, Inc.
INSY
$2.62M 0.52%
+224,673
New +$1.84M
GDP
38
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
$2.62M 0.52%
+107,720
New +$2.17M
AMCC
39
DELISTED
Applied Micro Circuits Corporation New
AMCC
$2.57M 0.51%
199,140
+75,886
+62% +$862K
PFPT
40
DELISTED
Proofpoint, Inc.
PFPT
$2.56M 0.51%
79,731
-21,254
-21% -$598K
RPRX
41
DELISTED
Repros Therapeutics Inc.
RPRX
$2.56M 0.51%
+95,476
New +$2.05M
MODV
42
DELISTED
ModivCare
MODV
$2.49M 0.5%
86,939
-15,627
-15% -$440K
OMER icon
43
Omeros
OMER
$845M
$2.48M 0.49%
+254,374
New +$1.52M
AMRI
44
DELISTED
Albany Molecular Research Inc
AMRI
$2.48M 0.49%
192,125
-39,977
-17% -$492K
RRGB icon
45
Red Robin
RRGB
$139M
$2.44M 0.49%
34,361
-8,263
-19% -$517K
GLBR
46
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$2.44M 0.49%
12,367
+5,787
+88% +$1.04M
CMLS
47
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$2.42M 0.48%
+57,199
New +$2.09M
CKEC
48
DELISTED
Carmike Cinemas Inc
CKEC
$2.41M 0.48%
109,001
+52,737
+94% +$1.02M
EIG icon
49
Employers Holdings
EIG
$907M
$2.38M 0.47%
80,008
+38,754
+94% +$1.06M
TNGO
50
DELISTED
Tangoe, Inc.
TNGO
$2.36M 0.47%
+98,911
New +$1.92M

Similar funds

EAM Investors's Q3 2013 Portfolio in Review

As of Q3 2013, EAM Investors held 430 positions worth $501M, up 8.9% from $461M the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

EAM Investors withdrew a net $54.9M in Q3 2013, closing 120 positions and reducing 166 holdings. Its most notable exit was TravelCenters of America LLC, an estimated $3.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Craft Brew Alliance, Inc. worth $3.44M.

  • EAM Investors's largest Q3 2013 buy was Craft Brew Alliance, Inc.: 256,052 shares worth $3.44M.
  • EAM Investors added most to BioTelemetry, Inc. in Q3 2013, an estimated $1.78M increase.
  • EAM Investors's biggest Q3 2013 reduction was Celldex Therapeutics, cutting an estimated $3.24M.
  • EAM Investors fully exited TravelCenters of America LLC in Q3 2013, selling an estimated $3.71M.
  • EAM Investors's ten largest holdings make up 8.8% of its $501M portfolio in Q3 2013.
  • EAM Investors opened 121 new positions and closed 120 in Q3 2013.
  • EAM Investors's portfolio value rose 8.9% quarter-over-quarter to $501M.

Based on EAM Investors's 13F filing for Q3 2013, filed 13 Nov 2013.